These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 6523430)

  • 21. The risk of recurrent venous thromboembolism in patients with and without factor V Leiden.
    Eichinger S; Pabinger I; Stümpflen A; Hirschl M; Bialonczyk C; Schneider B; Mannhalter C; Minar E; Lechner K; Kyrle PA
    Thromb Haemost; 1997 Apr; 77(4):624-8. PubMed ID: 9134632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Parameters of haemostasis during acute venous thrombosis.
    Reiter W; Ehrensberger H; Steinbrückner B; Keller F
    Thromb Haemost; 1995 Aug; 74(2):596-601. PubMed ID: 8584990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [A case of congenital protein C deficiency with pulmonary thromboembolism].
    Takeda K; Kumagai H; Hayashi S; Tanio Y; Kawase I; Kishimoto T; Fujiwara M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1994 May; 32(5):497-501. PubMed ID: 8084108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Family history for venous thromboembolism and the risk for recurrence.
    Hron G; Eichinger S; Weltermann A; Minar E; Bialonczyk C; Hirschl M; Stain M; Gartner V; Kyrle PA
    Am J Med; 2006 Jan; 119(1):50-3. PubMed ID: 16431184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recurrent thrombosis and survival after a first venous thrombosis of the upper extremity.
    Flinterman LE; van Hylckama Vlieg A; Rosendaal FR; Doggen CJ
    Circulation; 2008 Sep; 118(13):1366-72. PubMed ID: 18779446
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism.
    Eichinger S; Stümpflen A; Hirschl M; Bialonczyk C; Herkner K; Stain M; Schneider B; Pabinger I; Lechner K; Kyrle PA
    Thromb Haemost; 1998 Oct; 80(4):566-9. PubMed ID: 9798970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High antibody levels to prothrombin imply a risk of deep venous thrombosis and pulmonary embolism in middle-aged men--a nested case-control study.
    Palosuo T; Virtamo J; Haukka J; Taylor PR; Aho K; Puurunen M; Vaarala O
    Thromb Haemost; 1997 Oct; 78(4):1178-82. PubMed ID: 9364981
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thrombotic tendency in 75 symptomatic, unrelated patients with APC resistance.
    Melichart M; Kyrle PA; Eichinger S; Rintelen C; Mannhalter C; Pabinger I
    Wien Klin Wochenschr; 1996; 108(19):607-10. PubMed ID: 8921576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DVT and pulmonary embolism: Part II. Treatment and prevention.
    Ramzi DW; Leeper KV
    Am Fam Physician; 2004 Jun; 69(12):2841-8. PubMed ID: 15222649
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM
    Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Levels of prothrombin fragment F1+2 in patients with hyperhomocysteinemia and a history of venous thromboembolism.
    Kyrle PA; Stümpflen A; Hirschl M; Bialonczyk C; Herkner K; Speiser W; Weltermann A; Kaider A; Pabinger I; Lechner K; Eichinger S
    Thromb Haemost; 1997 Nov; 78(5):1327-31. PubMed ID: 9408013
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral anticoagulant therapy in venous thromboembolism.
    Cosmi B; Palareti G
    Semin Vasc Med; 2003 Aug; 3(3):303-14. PubMed ID: 15199464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombophlebitis and pulmonary embolism in the elderly patient.
    Kinasewitz GT
    Clin Chest Med; 1993 Sep; 14(3):523-36. PubMed ID: 8222567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral anticoagulation strategies after a first idiopathic venous thromboembolic event.
    Aujesky D; Smith KJ; Roberts MS
    Am J Med; 2005 Jun; 118(6):625-35. PubMed ID: 15922694
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Congenital thrombophilia among patients with venous thromboembolism.
    Melissari E; Monte G; Lindo VS; Pemberton KD; Wilson NV; Edmondson R; Das S; Kakkar VV
    Blood Coagul Fibrinolysis; 1992 Dec; 3(6):749-58. PubMed ID: 1489896
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Optimal duration of anticoagulant treatment of venous thromboembolism].
    Couturaud F; Grand'Maison A; Kearon C
    Presse Med; 2000 Jul 8-15; 29(24):1379-85. PubMed ID: 10938698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Disorders of fibrinolysis and thrombophilic states, risk factors and possibilities of dietary effects].
    Cepelák V; Dvorák J; Vít L; Cepeláková H; Beránek V
    Vnitr Lek; 1991 Jan; 37(1):13-20. PubMed ID: 2058093
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Thrombophlebitis and pulmonary embolism in congenital factor XII deficiency].
    Vergnes C; Lorient-Roudaut MF; Haissaguerre M; Roudaut R; Wicker P; Boisseau MR; Dallocchio M
    Arch Mal Coeur Vaiss; 1985 Mar; 78(3):440-3. PubMed ID: 3923976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Migratory venous thrombosis and cancer: mechanisms and clinical manifestations.
    Nusbacher J
    Prog Clin Cancer; 1967; 3():151-6. PubMed ID: 4867088
    [No Abstract]   [Full Text] [Related]  

  • 40. [Quantitative and qualitative hemostatic changes in 373 patients with recurring venous thromboses].
    Marbet GA; Duckert F; Biland L; Widmer LK
    Schweiz Med Wochenschr; 1985 Oct; 115(43):1505-6. PubMed ID: 4081679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.